Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2004-01-22
2010-12-14
Long, Scott (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C514S04400A, C424S186100
Reexamination Certificate
active
07850956
ABSTRACT:
This invention relates to a method of immunizing a vertebrate, comprising introducing into the vertebrate a DNA transcription unit which comprises DNA encoding a desired antigen or antigens. The uptake of the DNA transcription unit by a host vertebrate results in the expression of the desired antigen or antigens, thereby eliciting humoral or cell-mediated immune responses or both humoral and cell-mediated responses. The elicited humoral and cell-mediated immune response can provide protection against infection by pathogenic agents, provide an anti-tumor response, or provide contraception. The host can be any vertebrate, avian or mammal, including humans.
REFERENCES:
patent: 4722848 (1988-02-01), Paoletti et al.
patent: 4859465 (1989-08-01), Rutter
patent: 4861864 (1989-08-01), Atkinson et al.
patent: 4920209 (1990-04-01), Davis et al.
patent: 5049386 (1991-09-01), Eppstein et al.
patent: 5332658 (1994-07-01), Dyall-Smith et al.
patent: 5529777 (1996-06-01), Andrianov et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5620896 (1997-04-01), Hermann et al.
patent: 5693622 (1997-12-01), Wolff et al.
patent: 5703055 (1997-12-01), Felgner et al.
patent: 5827696 (1998-10-01), Estes
patent: 7566454 (2009-07-01), Lu et al.
patent: 2006/0014714 (2006-01-01), Robinson et al.
patent: 2132836 (1993-09-01), None
patent: 21666349 (1986-05-01), None
patent: WO 86/00930 (1986-02-01), None
patent: WO 86/07593 (1986-12-01), None
patent: 0292879 (1988-11-01), None
patent: WO 89/07140 (1989-08-01), None
patent: WO 90/02797 (1990-03-01), None
patent: WO 90/02803 (1990-03-01), None
patent: WO90/11092 (1990-10-01), None
patent: WO 90/11092 (1990-10-01), None
patent: WO 92/01045 (1992-01-01), None
patent: WO 92/03537 (1992-03-01), None
patent: 92/07941 (1992-05-01), None
patent: WO 92/08789 (1992-05-01), None
patent: 93/14269 (1993-07-01), None
patent: WO 93/17706 (1993-09-01), None
patent: WO 93/19183 (1993-09-01), None
patent: WO93/25235 (1993-12-01), None
patent: WO 95/20660 (1995-08-01), None
Morin et al. 84 (13): 4626. (1987).
Haynes et al. Science.1993; 260:1279-1286.
Weiss, Washington Post, p. A2, Apr. 30, 1997.
McCluskie et al (Mol Med May 1999;5:287-300).
Torres et al (J Immunol 1997;158:4529-32).
Nakano et al (J Virol 1997;71:7101-09).
Pistor et al. (Klin Wochenschr. 1988. 66:110-116).
Huylebroeck et al. (Gene. Jun. 1988. 66(2): 163-81).
Townsend et al. (Cell. Nov. 1984; 39(1):13-25).
Tite et al. (Immunology. 1990; 70:540-546).
Haynes, et al., “Gene-gun-mediated DNA Immunization Elicits Humoral, Cytotoxic, and Protective Immune responses,” Vaccines, 94:65-70 (1994).
Barry, et al, “Production of Monoclonal Antibodies by Genetic Immunization”, BioTechniques 16(4):616-619 (1994).
Brown, et al., “Assessment of Retrovirus-Expressed Nucleoprotein as a Vaccine against Lethal Influenza Virus Infections of Chickens”,Avian Diseases36:515-520 (1992).
Butini, L, et. al., “Comparative Analysis of HIV-Specific CTL Activity In Lymphoid Tissue and Peripheral Blood,”J. Cell Biochem.18B:147 (1994).
Cheng SM, et al., “Coexpression of biologically active simian immunodeficiency virus (SIV) Rev and Env in an SV40 system: the SIV rev gene regulates env expression,”Virology177(2):816-9 (1990).
Cohen OJ., et al., “HIV/AIDS in 1998—gaining the upper hand?”JAMA. 280(1):87-8 (1998).
Cox, et al., “Bovine Herpesvirus 1: Immune Reponses in Mice and Cattle injected with Plasmid DNA”,J. of Virol. 67(9):5664-5667 (1993).
Davis, et al., “Direct Gene Transfer into Skeletal Muscle In Vivo: Factors Affecting Efficiency of Transfer and Stability of Expression”,Human Gene Therapy4:151-159 (1993).
Davis, et al, “DNA-Based Immunization Induces Continuous Secretion of Hepatitis B Surface Antigen and High Levels of Circulating Antibody”,Human Molecular Genetics2(11):1847-1851 (1993).
Davis, et al., “Plasmid DNA Is superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal Muscle”,Human Gene Therapy4:733-740 (1993).
Eisenbraun et al., “Examination of Parameters Affecting the Elicitation of Humoral Immune Responses by Particle Bombardment-Mediated Genetic Immunization”,DNA and Cell Biology12(9):791-797 (1993).
Fooks AR, et al., “High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model,”Virology210(2):456-65 (1995).
Fynan, et al., “DNA Vaccines: Protective Immunizations by Parenteral, Mucosal, and Gene-Gun Inoculations”,Proc. Natl. Acad. Sci.USA 9:11748-11482 (1993).
Fynan, et al., “Use of NDA Encoding Influenza Hemagglutinin as an Avian Influenza Vaccine”,DNA and Cell Biology12(9):785-789 (1993).
Gardner, M.B., “Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vacines and antiviral agents”,Antiviral Research15:267-286 (1991).
Gardner, M.D., “SIVInfection of Macaques: A Model for Aids Vaccine Development”, 21stCongress of the IABS, Annecy, France (1989).
Gelder CM, et al., “Human CD4+ T-cell recognition of influenza a virus hemagglutinin after subunit vaccination,”J Virol. 70(7):4787-90 (1996).
Gilboa E., et al., “Gene therapy for infectious diseases: the AIDS model,”Trends Genet.10(4):139-44 (1994).
Glaser, V.,Genetic Engineering News16:6 (1996).
Haynes BF, “Scientific and social issues of human immunodeficiency virus vaccine development,”Science260(5112):1279-86(1993).
Hoffenbach A., et al., “Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans,”J Immunol. 142(2):452-62 (1989).
Hunt, et al., “Retrovirus-Expressed Hemagglutinin Protects against Lethal Influenza Virus Infections”,J. of Virol. 62(8):3014-3019 (1988).
Huylebroeck, et al., “Viral delivery systems for Heterologous Antigens and Epitopes”,Technological Advances in Vaccine Development84:279-293 (1988).
Johnson, et al., “SIV Infection of Macaques as a Model for AIDS Pathogenesis”,Intern. Rev. Immunol. 8:55-63 (1992).
King, “Viral gene delivery technique may improve on HIV and other vaccines”,Biotechnology News11(28):5 (1991).
Kuby, J., “Immunology,”W.H. Freeman&Co., NY (1991).
Ledley FD, “Clinical considerations in the design of protocols for somatic gene therapy,”Hum Gene Ther. 2(1):77-83 (1991).
Liu et al., “Immunization with DNA Encoding a Conserved Internal Viral Protein Results in Protection from Morbidity and Mortality Due to Challenge with Influenza A in Mice”, Abstracts of papers presented 1992 meeting onModern Approaches to New Vaccines Including Prevention of AIDS, Cold Spring Harbor Laboratory, New York, Sep. 16-20 1992.
McClure, et al., “Nonhuman Primate Models for Evaluation of AIDS Therapy”,Annals New York Academy of Sciences616:287-98 (1990).
Montgomery, et al., “Heterologous and Homologous Protection Against Influenza A by DNA Vaccination: Optimization of DNA Vectors”, DNA and Cell Biology 12(9):777-783 (1993).
Nable, et al., “Direct Gene Transfer for Immunotherapy and Immunization”,Trends in Biotechnology11(5):211-215 (1993).
Parker, et al., “Intramuscular Vaccination of Plasmid DNA Containing Viral Antigens Provides Protection Against a Lethal Viral Challenge”, Abstracts of papers presented 1992 meeting onModern Approaches to New Vaccines Including Prevention of AIDS, Cold Spring Harbor Laboratory, New York, Sep. 16-20, 1992.
Rekosh D., et al., “Coexpression of human immunodeficiency virus envelope proteins and tat from a single simian virus 40 late replacement vector,”Proc Natl Acad SciUSA 85(2):334-8 (1988).
Rhodes et al., “Injection of Expression Vectors Containing Antigen Genes Induce Cellular and Humoral Immunity to the Antigen”, Abstracts of papers presented 19
Fynan Ellen F.
Lu Shan
Robinson Harriet L.
Webster Robert G.
Fish & Richardson P.C.
Long Scott
St. Jude Children's Research Hospital
University of Massachusetts Medical Center
LandOfFree
Immunization by inoculation of DNA transcription unit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunization by inoculation of DNA transcription unit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunization by inoculation of DNA transcription unit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4234384